30 March 2025, Volume 35 Issue 3
Specialist's Commentary

Advances and controversies in the adjuvant treatment of early breast cancer

WANG Zhiqing, LIU Xiyu, FAN Lei

2025, 35 (3): 255-262. doi: 10.19401/j.cnki.1007-3639.2025.03.001

Abstract ( 76) PDF (1164KB) ( 55 ) HTML ( 6 )

Current status and future perspectives on consensus and controversies in advanced breast cancer for 2024

WANG Xiaobo, WANG Tao

2025, 35 (3): 263-272. doi: 10.19401/j.cnki.1007-3639.2025.03.002

Abstract ( 72) PDF (1138KB) ( 89 ) HTML ( 5 )

Precision diagnosis and treatment of breast cancer in the post-CDK4/6 inhibitor era

LI Bin, TAO Zhonghua, HU Xichun

2025, 35 (3): 273-282. doi: 10.19401/j.cnki.1007-3639.2025.03.003

Abstract ( 62) PDF (1147KB) ( 79 ) HTML ( 4 )

Advances and controversies in new techniques of breast pathology

ZHANG Yujia, MA Li

2025, 35 (3): 283-290. doi: 10.19401/j.cnki.1007-3639.2025.03.004

Abstract ( 58) PDF (1160KB) ( 75 ) HTML ( 5 )

Specialist's Article

Survival analysis of female breast cancer in Shanghai: a population-based study from 2002 to 2017

WU Chunxiao, PANG Yi, GU Kai, YAN Jiaying, WANG Chunfang, XIANG Yongmei, SHI Yan

2025, 35 (3): 291-297. doi: 10.19401/j.cnki.1007-3639.2025.03.005

Abstract ( 45) PDF (1065KB) ( 43 ) HTML ( 2 )

Article

A study on the correlation between HPV DNA and IHC P16 expression in cervical lesions

WANG Haochen, JIA Liqing, YANG Yu, WANG Qian, YU Chengli, TIAN Tian, BI Rui, TU Xiaoyu, BAI Qianming, ZHU Xiaoli, ZHOU Xiaoyan, REN Min

2025, 35 (3): 298-308. doi: 10.19401/j.cnki.1007-3639.2025.03.006

Abstract ( 54) PDF (2134KB) ( 43 ) HTML ( 2 )

Effects of SEC14L1P1 on proliferation and migration of oral squamous cell carcinoma cells

ZHENG Wentian, GONG Hui, ZHANG Xinyue, HAO Jiayi, WANG Yajie, JIANG Yingying

2025, 35 (3): 309-319. doi: 10.19401/j.cnki.1007-3639.2025.03.007

Abstract ( 42) PDF (2473KB) ( 56 ) HTML ( 7 )

Relationship between quantitative analysis parameters of DCE-MRI and microangiogenesis in rectal cancer

SONG Dan, CHAI Yaxin, GE Yanping

2025, 35 (3): 320-325. doi: 10.19401/j.cnki.1007-3639.2025.03.008

Abstract ( 46) PDF (1399KB) ( 19 ) HTML ( 1 )

Review

Research status and prospects of treatment for malignant pleural mesothelioma

ZHAO Kaile, WANG Lei, GENG Jianxiong, CUI Chengwei, YU Yan

2025, 35 (3): 326-332. doi: 10.19401/j.cnki.1007-3639.2025.03.009

Abstract ( 64) PDF (984KB) ( 64 ) HTML ( 3 )

Research progress on treatment of pleural effusion related to immune checkpoint inhibitors

AN Tianqi, TIAN Jianhui, ZHOU Yiyang, LUO Bin, QUE Zujun, LIU Yao, YU Pan, ZHAO Ruihua, YANG Yun

2025, 35 (3): 333-338. doi: 10.19401/j.cnki.1007-3639.2025.03.010

Abstract ( 51) PDF (979KB) ( 41 ) HTML ( 2 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat